Stocks
AnaptysBio (ANAB) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 3.88 | 20.3 | 9.46 | 4.01 | 2.61 | 3.29 | |||
| Changes by years, y/y, % | -44% | +424% | -53% | -58% | -35% | -17.8% | |||
AnaptysBio. Debt/EBITDA
AnaptysBio. Debt/EBITDA, changes, %
AnaptysBio (ANAB) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 3.05 | 2.60 | 0.19 | -0.20 | 3.29 | 3.29 | ||
| Changes by years, y/y, % | -15% | -35% | -95% | -106% | +8% | |||
| Changes by quarters, q/q, % | -8% | -15% | -93% | -204% | -1 752% | |||
